1. Home
  2. LNTH vs NIO Comparison

LNTH vs NIO Comparison

Compare LNTH & NIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lantheus Holdings Inc.

LNTH

Lantheus Holdings Inc.

N/A

Current Price

$99.65

Market Cap

6.6B

Sector

Health Care

ML Signal

N/A

Logo NIO Inc. American depositary shares each  representing one ordinary share

NIO

NIO Inc. American depositary shares each representing one ordinary share

N/A

Current Price

$3.41

Market Cap

12.7B

ML Signal

N/A

Company Overview

Basic Information
Metric
LNTH
NIO
Founded
1956
2014
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Auto Manufacturing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.6B
12.7B
IPO Year
2014
2018

Fundamental Metrics

Financial Performance
Metric
LNTH
NIO
Price
$99.65
$3.41
Analyst Decision
Hold
Buy
Analyst Count
10
24
Target Price
★ $107.74
$6.30
AVG Volume (30 Days)
805.3K
★ 28.1M
Earning Date
11-05-2026
09-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ 2.91
N/A
Revenue
★ $343,374,000.00
N/A
Revenue This Year
N/A
$46.59
Revenue Next Year
$10.29
$19.07
P/E Ratio
$34.19
★ N/A
Revenue Growth
★ 3.62
N/A
52 Week Low
$49.67
$3.38
52 Week High
$111.86
$7.86

Technical Indicators

Market Signals
Indicator
LNTH
NIO
Relative Strength Index (RSI) 38.96 26.74
Support Level $98.81 N/A
Resistance Level $101.24 $3.79
Average True Range (ATR) 0.40 0.08
MACD -0.04 0.01
Stochastic Oscillator 18.97 10.98

Price Performance

Historical Comparison
LNTH
NIO

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.

About NIO NIO Inc. American depositary shares each representing one ordinary share

Nio is a leading electric vehicle maker, targeting the premium segment. Founded in November 2014, Nio designs, develops, jointly manufactures, and sells premium smart electric vehicles. The company differentiates itself through continuous technological breakthroughs and innovations, such as battery swapping and autonomous driving. Nio launched its first model, its ES8 seven-seater electric SUV, in December 2017, and began deliveries in June 2018. Its current model portfolio includes midsize to large sedans and SUVs. It sold around 326,000 EVs in 2025, accounting for about 2% of China's passenger new energy vehicle market.

Share on Social Networks: